This study investigates the effects of topical ophthalmic prednisolone (steroid) and diclofenac (nonsteroidal anti-inflammatory drug) on diabetes mellitus regulation in client-owned dogs.
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance.
The goal of this study is to determine new strategies for treating canine mast cell tumors based on the targeting of a DNA-packaging protein called NDY1.
